Most of these are designed to be more potent and specific inhibitors of CypD, including the small molecules C-9, C-19, and C-31, which have already been proven to be protective in models of AD, acute pancreatitis, and hepatic injury [223,224,225]. Here, PPIF is linked to Alzheimer disease.